Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Potawatomi Support Services Now Offering COVID-19 Rapid Antigen Test Kits


News Image

“This is the 3rd COVID-19 testing option in Potawatomi Support Services’ COVID-19 Testing Solution.” – Peyton Brauer, Senior Vice President PBDC- Federal Group

Potawatomi Support Services, LLC (PSS) now provides FDA Emergency Use Authorized (EUA) rapid, COVID-19 Antigen Test Kits. The rapid Antigen Test Kits is the 3rd COVID-19 testing option PSS offers, including Rapid Antibody Test Kits and PCR testing.

PSS rapid Antigen Test Kits can provide test results in 10 minutes or less, with a minimally invasive nasopharyngeal specimen collection. Antigen Tests are produced at a much lower cost than conventional PCR testing, and other rapid Antigen Tests. PSS’s rapid Antigen Test Kits do not require a separate machine for processing results. Each box comes with everything needed to perform, process, and read the results (20 test kits per box).

PSS has the rapid Antigen Test Kits and the rapid Antibody Test Kits available for immediate shipment. We offer a full COVID-19 testing solution from supplying the test kits as a stand-alone option, to providing full-spectrum testing services, licensed medical personnel, PCR testing, CLIA oversight, training, and reporting. Test kits are intended for Point of Care use, for surveillance and/or screening purposes.

About the Potawatomi Support Services:

Potawatomi Support Solutions is an SBA-Certified 8(a) subsidiary of Potawatomi Business Development Corporation (PBDC). As an American Indian Tribal (AIT) Corporation, PBDC-Federal Group provides Potawatomi Support Services with the corporate infra-structure, processes, and financial support of a much larger organization, allowing our customers to recognize the benefits while still maintaining access to small and agile Primes. As part of the PBDC family of companies, PSS shares common administrative services with each other. This support grants us access to human capital, well-proven processes, and a wealth of knowledge that spans over all twelve companies.

Share article on social media or email:

Acclaimed Plastic Surgeon Dr. Ran Stark Opens New, State-of-the-Art Surgical and Aesthetic Practice — Stark MD Plastic Surgery & Aesthetic Center — in Bryn Mawr, PA


Acclaimed Plastic Surgeon Dr. Ran Stark of Bryn Mawr, PA

“I am deeply passionate about my work,” says Dr. Stark, “and take pride in restoring self-confidence by pursuing the best results possible to make my clients the greatest version of themselves.”

Double board-certified plastic surgeon Dr. Ran Stark is thrilled to open Stark MD Plastic Surgery & Aesthetic Center, a leading new aesthetic practice on the Main Line in Bryn Mawr, PA. Stark MD Plastic Surgery and Aesthetic Center officially opened September 14, 2020.

Dr. Stark is a highly accomplished plastic surgeon who is committed to providing the highest level of plastic surgery and aesthetic services with a caring and attentive bedside manner. Trained by the best, Dr. Stark is driven to deliver impeccable results and a truly extraordinary patient experience. “I am deeply passionate about my work,” says Dr. Stark, “and take pride in restoring self-confidence by pursuing the best results possible to make my clients the greatest version of themselves.”

Stark MD Plastic Surgery and Aesthetic Center offers a leading and comprehensive menu of both plastic surgery and non-surgical aesthetic treatments. For plastic surgery, Dr. Stark’s services include surgeries of the face, breast and body including:

  • Breast augmentation
  • Breast lift
  • Tummy tuck
  • Facelift
  • Brow lift
  • Eyelid surgery
  • High-Definition (HD) Liposuction
  • Mommy Makeovers
  • Brazilian Butt Lift (BBL)
  • Thigh lift and more

For non-invasive aesthetic services, Dr. Stark offers a wide range of age-defying skin rejuvenation and body contouring treatments, including:

  • BodyTite, AccuTite and FaceTite for skin tightening
  • Chemical peels
  • Halo® laser skin resurfacing
  • BBL™ photofacial
  • Morpheus8 microneedling RF
  • Non-surgical butt lift
  • Injectables: Dermal Fillers and Botox/Dysport
  • Scar revision and much more

Stark MD Plastic Surgery and Aesthetic Center is located at 135 South Bryn Mawr Avenue, Suite 220, Bryn Mawr, PA 19010. To schedule a consultation, please call 484-482-8809 or complete a consultation request form.

About Ran Stark, M.D.

Ran Stark, M.D. is double board-certified by the American Board of Plastic Surgery and the American Board of Surgery. Pursuing his passion for surgery, Dr. Stark completed six years of general surgery training at the Morristown Medical Center. While there, he received the prestigious Hughs D. Dougan, M.D. award for exemplary devotion to patient care, attention to detail and excellence in surgical technique. Dr. Stark then went on to complete a residency in plastic and reconstructive surgery at the University of Texas Southwestern, one of the nation’s top training programs in its field. His keen attention to detail, artistic eye, and practiced hands help give his patients consistently exemplary results. Yet the Stark difference is also in his bedside manner. Dr. Stark makes your goals his own. He will always do the utmost to help you uncover the greatest version of yourself.

Share article on social media or email:

Brain Center TMS Now Offers TMS Treatment for Veterans with Tinnitus


Brain Center TMS, a mental health treatment center in San Diego, is now helping veterans treat their tinnitus through insurance-covered Transcranial Magnetic Stimulation, also known as TMS.

According to Military.com, tinnitus affects at least one in every 10 American adults. And, it is the number one disability among veterans. The U.S. Department of Veterans Affairs states that there were 993,000 veterans in 2014 claimed disability from hearing loss and 1.3 million claimed disability for tinnitus.

Tinnitus is a disability where the victim hears ringing in one or both ears. It falls under two categories. The first being subjective tinnitus, whereby only the sufferer can hear the noise. The second being objective tinnitus, where the noise can be in the middle ear heard by an examiner.

Veterans are often affected by tinnitus because of what they experienced while in service. Loud gunfire, machinery, and aircraft noise military personnel are exposed to can lead to both hearing loss and tinnitus.

In 2018, National Center for Rehabilitative Auditory Research (NCRAR) at the VA Portland Health Care System developed the Progressive Tinnitus Management program to help nearly 2 million veterans with tinnitus. In this plan, NCRAR lists TMS under their “First Approach: Eliminate Tinnitus or Reduce its Loudness.”

Before TMS, there were not many effective treatments for subjective tinnitus. Symptoms have historically been treated with prescription drugs and psychological approaches. In rare cases, surgery has been one approach for objective tinnitus.

Improvements and research in TMS technology have allowed scientists and doctors to treat tinnitus with a well-tolerated procedure. Though TMS is not a popular treatment at the moment, facilities like Brain Center TMS have been leading the push for a newer approach to tinnitus as well as other disabilities.

Brain Center TMS in San Diego has been providing inpatient and outpatient psychiatric treatment since 2005. They have seen TMS therapy become an effective approach for ailments such as treatment-resistant depression and obsessive-compulsive disorder.

Because it is a newer treatment, many popular insurance providers only cover TMS in certain circumstances. However, the Defense Health Agency (DHA) issued TRICARE insurance that covers many military veterans now covers TMS for tinnitus as well as other conditions.

Brain Center TMS claims that many of their tinnitus patients who have received TMS see significant improvement in their symptoms. Outside research points to similar results.

Research center JAMA Otolaryngology published a randomized clinical trial on 64 veterans with tinnitus. Thirty-two veterans received 10 sessions of TMS, while the other 32 received fake TMS treatment.

In the study, 56 percent of the veterans who received real TMS saw significant improvement while only 22 percent of those who received the fake TMS saw improvement.

Share article on social media or email:

Tutera Senior Living & Health Care Earns 2020 Quality Awards from the American Health Care Association and National Center for Assisted Living


Tutera Senior Living & Health Care is a locally owned, diversified post-acute senior health care provider operating 70 senior living communities in nine states throughout the country.

It’s rewarding to be recognized with a prestigious quality award that underscores the standards that guide what we do every day.

Tutera Senior Living & Health Care is proud to announce two of its communities in Missouri have earned prestigious Quality Awards from the American Health Care Association (AHCA)/National Center for Assisted Living (NCAL), the leading association for long term and post-acute care providers. The annual award honors association members across the nation that have demonstrated their commitment to improving quality of care for seniors and persons with disabilities.

With 70 facilities, communities and agencies in nine states throughout the United States, Tutera is one of the nation’s premier providers of diversified, post-acute senior health care services. The following two Tutera communities have earned the 2020 Silver Achievement in Quality or Bronze Commitment to Quality Award:

“We are proud to see these communities recognized for their unwavering commitment to residents,” said Joe Tutera, chief executive officer of Tutera Senior Living & Health Care. “I commend the staff at these two communities on their hard work and dedication to our valued residents.”

The Bronze Commitment to Quality Award and the Silver Achievement in Quality Award are two of three progressive award levels through the National Quality Award Program, which AHCA/NCAL established in 1996. It is based on the core values and criteria of the Baldrige Performance Excellence Program, which is also the foundation of the metric-based AHCA/NCAL Quality Initiative. The Baldrige program helps organizations in different business sectors improve and achieve performance excellence.

“It’s rewarding to be recognized with a prestigious quality award that underscores the standards that guide what we do every day,” said Randy Bloom, Ph.D., chief operating officer of Tutera Senior Living & Health Care. “Our ongoing YOUNITE initiative is designed to ensure we are continuously asking, listening and responding in ways that are personally meaningful to residents, family members and staff in all our communities across the nation.”

Bronze applicants must demonstrate their ability to implement a performance improvement system. Silver applicants must have previously received the Bronze Commitment to Quality Award. Silver award winners demonstrate effective approaches that help improve performance and health care outcomes. Trained examiners thoroughly review each application to determine if the center has met the demands of the criteria.

The 2020 awards were presented during AHCA/NCAL’s virtual 71st National Quality Award Ceremony on October 22, 2020.

About Tutera Senior Living & Health Care

Tutera Senior Living & Health Care is a locally owned, diversified post-acute senior health care provider operating 70 senior living communities in nine states throughout the country. As one of the nation’s premier senior care providers, Tutera Senior Living & Health Care offers its residents independent living, assisted living, skilled nursing, post-surgery rehabilitation, memory care, home health and hospice care. In 1983, Dominic F. Tutera, M.D., founded Tutera to provide compassionate patient care with the uncompromising values of integrity, accountability and commitment. Tutera Senior Living & Health Care still embodies those values today. Tutera is committed to making a positive difference in the lives of its residents and their families through senior living and health care experts who inspire and promote individuality and personal happiness. For more information, visit http://www.Tutera.com.

About AHCA/NCAL

The American Health Care Association and National Center for Assisted Living (AHCA/NCAL) represent more than 14,000 non-profit and proprietary skilled nursing centers, assisted living communities, sub-acute centers and homes for individuals with intellectual and developmental disabilities. By delivering solutions for quality care, AHCA/NCAL aims to improve the lives of the millions of frail, elderly and individuals with disabilities who receive long term or post-acute care in our member facilities each day. For more information, please visit http://www.ahcancal.org.

Share article on social media or email:

Defying Health Care Disparities and Clinical Trial Barriers in Pediatric Populations, Upcoming Webinar Hosted by Xtalks


Inclusion of adolescents in adult clinical trials will increase young patients access to safe and efficacious treatments in a timely manner.

The PRA Health Sciences Center for Pediatric Clinical Development’s second annual acknowledgement of World Children’s Day will be celebrated virtually on November 16, 2020. World Children’s Day is celebrated to commemorate the Convention on the Rights of the Child, which is the most widely ratified human rights treaty in history and has helped transform children’s lives around the world. It sets defined parameters to ensure humanity recognizes the equality necessary for children to develop to their full potential.

PRA Health Sciences is promoting international togetherness and awareness of children worldwide, as well as improving children’s welfare.

In this webinar, the speakers will discuss ongoing health disparities and social determinants, diversity (and the lack thereof) in clinical trial participation, inclusion of adolescents in adult clinical trials, clinical trial education of the public and survey results of the “Pediatric Perceptions and Insights” study conducted by the Center for Information and Study on Clinical Research Participation (CISCRP).

Being a member of a racial or ethnic minority, compounded with the lack of awareness and health care access, continue to be a barrier to bringing appropriate clinical trial participation and safe and effective treatments for chronic and debilitating diseases to the pediatric population. Panelists will discuss experienced barriers and how to defy prejudice and encourage diversity.

Inclusion of adolescents in adult clinical trials will increase young patients access to safe and efficacious treatments in a timely manner. Including the ages of 12 to under 18 years in adult clinical trials will eliminate the extended time while waiting for the adult trial results and may help for trial design to support pediatric indications when warranted based on preliminary results. Not including adolescents leads to off label prescribing lacking scientific evidence of safe and efficacious dosing.

The live webinar will include a panel discussion with three young adults moderated by Dr. Gaspar. Two of the young adult panelists have participated in adult clinical trials as adolescents and one panelist with a rare disease sharing barriers of participation and advocacy to create a collaborative platform for patients and researchers.

Join Dr. Hemant Malhotra, Medical Oncologist, Department of Medical Oncology, Mahatma Gandhi College Hospital; Dr. Nathalie Gaspar, Paediatric Oncologist, Gustave Roussy Cancer Campus; Annick deBruin, Senior Director of Research Services, CISCRP, in the live webinar on Monday, November 16, 2020 at 10am EST (3pm GMT/UK).

The webinar will also feature youth panelists Benjamin James, an MSc (Merit) Science communication graduate from the University of Sheffield who has Duchenne Muscular Dystrophy (DMD) and is a trustee for Pathfinders Neuromuscular Alliance; Rime Allouche, who is a member of KIDS France and advocates to ensure the voice of children and young adults is represented in clinical trials; and Max Williamson, a young cancer patient and patient advocate on the Teenage and Young Adult Cancer research group of the UK’s National Cancer Research Institute.

For more information, or to register for this event, visit PRA’s World Children’s Day Event: Defying Health Care Disparities and Clinical Trial Barriers in Pediatric Populations.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Advancing Imaging Operations & Analysis in Alzheimer’s Disease Late-Stage Clinical Trials, Upcoming Webinar Hosted by Xtalks


In view of the large and complex data sets within Phase III trials, this webinar will present the advanced TrialTracker platform for scaling-up processes and systems to manage imaging data, from radiological read workflow to imaging analysis.

Phase III clinical trials are required to prove the effectiveness and safety of a drug in a larger population. After decades of research, Alzheimer’s disease still has no disease-modifying drug that is approved as many of the drug development programs fail in later-stage phases. Due to the complexity of the disease and challenges associated with large scale later phase studies, Phase III Alzheimer’s clinical trials require neuroimaging approaches that successfully blend robust operational infrastructure, effective data management platform and advanced analytics.

This webinar will address practices to optimize the entire operational lifecycle including site qualification, investigator training and radiological reads in Alzheimer’s clinical trials.

In view of the large and complex data sets within Phase III trials, this webinar will present the advanced TrialTracker platform for scaling-up processes and systems to manage imaging data, from radiological read workflow to imaging analysis. It will additionally cover the AI-driven LEAP platform used to perform advanced segmentation and volumetric analysis in Alzheimer’s trials.

Join Roger Bullock, Chief Medical Officer, Oryzon; Shona Clegg, Senior Project Manager/Portfolio Lead, IXICO; and Richard Joules, Imaging Science Manager, IXICO in a live webinar on Friday, November 13, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Advancing Imaging Operations & Analysis in Alzheimer’s Disease Late-Stage Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

The Benefits of the Global Reach, Upcoming Webinar Hosted by Xtalks


So, what are the risks involved in clinical trial supplies and comparator sourcing and how can you manage these risks to ensure a successful clinical trial on a global scale?

Running a successful clinical trial relies heavily on the management of risks within the supply chain. Risk management is an essential part of clinical trials to ensure that sponsors can generate a clear return on investment without disruptions. It’s a complex process of identification and management depending on a number of factors that can impact the effectiveness of the trial. There is no ‘one size fits all’ approach. Each clinical trial has its own complexities based on the comparator, data and stock shortages which can delay timelines and increase costs. Mistakes can prove very expensive and more importantly, put patient safety at risk.

Successful clinical trials need effective supply chain management procedures to make sure risks are identified and managed in a timely manner, so that the required medication is available at the site when needed. Taking a holistic approach to assessing and managing risks makes sure that sponsors can prevent things that will impact the trial and the data generated. There needs to be a robust methodology in place for identifying, evaluating and proactively managing the risks involved in clinical trials. Having the benefit of a global reach and multiple sources can make a tremendous difference to the options available.

So, what are the risks involved in clinical trial supplies and comparator sourcing and how can you manage these risks to ensure a successful clinical trial on a global scale?

Join Vanessa Dekou, PhD, Managing Director, Clinical Services International (CSI) and Kotaro Yoshizawa, Chief Representative Japan-Global, CSI in a live webinar on Monday, November 16, 2020 at 9am EST (2pm GMT/UK) to find out.

For more information or to register for this event, visit How to Identify and Manage Risks in Clinical Trial Supplies and Comparator Sourcing: The Benefits of the Global Reach.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

CardieX Launches ATCOR·X to License Advanced Cardiovascular Health Technology for Wearables


heart health, apple watch, fitbit, garmin

Under the ATCOR·X brand, CardieX will develop and license its Arty™ platform, featuring a unique set of heart and arterial health measurements

COVID-19 has created an unprecedented opportunity to create a healthcare ecosystem integrated into people’s homes and daily lives using innovative home devices and wearables,” said Craig Cooper, CEO and Managing Director of CardieX.

CardieX Limited (ASX: CDX), a global health technology company focused on hypertension, cardiovascular disease, and vascular health disorders, today announced the launch of ATCOR·X, a new division focused on developing and licensing clinically meaningful health data algorithms for consumer wearables and connected fitness devices. ATCOR·X wearable features are based on the company’s FDA-cleared and patented SphygmoCor® technology for measuring arterial waveforms and central blood pressure.

“The seismic shift to remote care driven by COVID-19 has created an unprecedented opportunity to create a healthcare ecosystem integrated into people’s homes and daily lives using innovative home devices and wearables,” said Craig Cooper, CEO and Managing Director of CardieX. “We’re launching ATCOR·X to accelerate development and drive adoption of our SphygmoCor® technology – the global gold-standard for non-invasive measurement of central blood pressure waveforms and arterial stiffness – and to improve the health of millions of Americans with hypertension as well as those who have lasting cardiovascular damage as a result of COVID-19.”

Under the ATCOR·X brand, CardieX will develop and license its Arty™ platform consisting of a unique feature set of enhanced biometric heart and arterial health measurements that can be tailored for risk assessment and to manage cardiovascular and renal disease, dementia and Alzheimer’s disease, arterial stiffness and vascular aging, diabetes, maternal health, and other chronic disease.

These include:


  • Heart Stress™ (HS) – Measures the level of stress on the heart due to the hardening of arteries, which can be a sign of cardiovascular risk.
  • Exercise Capacity™ (eCap) – Measures the heart’s ability to provide oxygenated blood to cells based on the body’s performance demands. Unlike VO2 max, eCap indicates potential exercise endurance based on cardiovascular health.
  • Heart Rate (HR+™) – Provides accurate, medical-grade, beat-to-beat heart rate (HR) measurement equivalent to standard ECG-based methods with greater accuracy than HR measurements common in other wearables.
  • Arterial Age™ – Compares an individual’s heart health with healthy people their age to indicate the biological age of their heart compared to chronological age.
  • Arterial Stiffness Factor™ (ASF) – Measures the flexibility of an individual’s arterial and vascular system to indicate risk for cardiovascular events tied to arterial stiffness, such as heart attack, stroke, and dementia.
  • Irregular Heartbeat – Helps an individual identify if they are experiencing an abnormal heartbeat without the use of an ECG, which may be a sign of atrial fibrillation.
  • HRV+™ – Heart Rate Variability Plus provides beat-to-beat HR measurement of a user’s autonomic nervous system (ANS), parasympathetic (rest and relax) and sympathetic (fight or flight) nervous systems to indicate biological stress.
  • Vitals Risk™ – Identifies the risk of heart, brain, and other organ damage from cardiovascular disease based on the user’s own data.
  • BP Variability (BPV+™) – Shows the variability of brachial blood pressure, representing how stable one’s blood pressure is over time.
  • Heart Performance Index™ (HPX) – Measures how efficiently an individual’s heart works to meet the body’s demand for oxygen and blood flow indicating how healthy an individual is. Research has shown exercise and a healthy lifestyle can help improve your HPX score and improve your day to day performance.
  • Arty™ Score – Combines Heart Stress, Exercise capacity (eCAP), Heart Rate (HR+), and Arterial Age to quantify an individual’s unique heart and arterial health risk profile.

The above measures can be combined into comprehensive cardiovascular dashboards and also can be used to develop personalized fitness, diet and lifestyle coaching services to help individuals improve their health through nutrition and exercise.

ATCOR·X builds on the Company’s recently announced commercial partnerships and integrations with both Mobvoi, one of the world’s largest smartwatch and AI companies, and Andon, one of Chinas largest manufacturers of home medical devices.

About CardieX

CardieX is a global health technology company that focuses on hypertension, cardiovascular disease, and other vascular health disorders. The company’s ATCOR division is the world leader in medical devices for measuring arterial stiffness and central blood pressure waveforms based on its unique FDA-cleared and patented SphygmoCor® technology. Under the ATCOR·X brand, the company also develops and licenses its Arty™ platform consisting of physiological and health analytics for wearable devices. The company’s digital platform, ArtyNet™, is a connected SaaS ecosystem providing physicians with a complete telehealth solution for remotely managing patients’ health (2021 launch). CardieX is listed on the Australian Stock Exchange (ASX:CDX).

Share article on social media or email:

Inpathy Now In-Network with Aetna in Additional States


Aetna, a CVS Health company, and Inpathy are pleased to announce that their relationship has expanded to provide access to mental health care to additional Aetna members in Illinois, Texas and Florida. Aetna and Inpathy have collaborated since 2016. This expansion ensures that individuals have access to convenient online psychiatry and therapy services anytime, anywhere. As of September 1, 2020, Inpathy, a telehealth provider service can be used in-network with Aetna health insurance by residents of Illinois, Texas, Florida California, Colorado, Delaware, Missouri, New Jersey, New York, Pennsylvania and Virginia.

Inpathy has been providing mental health care entirely virtually for the past seven years and is a covered benefit for more than 25 million individuals across the country. Not only has telebehavioral health services like Inpathy proven to be an effective form of delivering care, but now, due to COVID-19, it is the preferred form of care. According to the MMWR and Morbidity and Mortality Weekly Report, in June 2020, 40% of U.S. adults reported struggling with mental health or substance use associated with COVID-19. The same report showed that the prevalence of anxiety disorder symptoms were up approximately three times than the same prevalence in 2019 while the prevalence of depressive disorder was approximately four times higher.

Telebehavioral health allows payers to meet the growing mental health needs of their members who may be experiencing additional stress and anxiety caused by social isolation and the spread of COVID-19. Through Inpathy, Aetna members can fit sessions into busy days, cut out any travel time and expense, skip the waiting room, reduce expensive ED visits and hospitalizations, and connect to a large network of clinicians to receive the high-quality care they deserve. An Inpathy survey showed that 96% of their members prefer online to in-person care and 98% of members felt more engaged in their care.

“We are pleased to expand our long-time partnership with Inpathy to offer additional options to our members and increase access to mental well-being services in even more states,” explained Dr. Hyong Un, Chief Psychiatric and Innovation Officer at Aetna Behavioral Health. “More members will be able to access mental health televideo counseling services from the safety of their home. Having easy access to providers is extremely beneficial for improving mental and emotional health.”

“Aetna recognized the rising need for mental health services. We are proud to partner with them to bring these services to their members,” said Justine Mitchell, Vice President of Inpathy. “Our care navigation team will work with members to find the right behavioral health provider and support members pre and post appointments.”

About Inpathy

Inpathy is InSight + Regroup’s direct-to-consumer division and is designed to deliver psychiatric, behavioral and mental health care to individuals through secure, convenient, online video calls. Inpathy has a platform for delivering behavioral health services, an online marketplace for finding those services and a network of clinicians who operate under InSight + Regroup’s support and management to deliver high quality care. While InSight + Regroup’s other divisions bring psychiatrists and mental health clinicians to community-based facilities and organizations through telehealth, Inpathy uniquely brings life-changing behavioral health care directly into people’s homes or any private place that they choose to access it.

Share article on social media or email:

Periodontist Lisa Ravenel Adds LANAP Laser Procedure for Treating Gum Disease


LANAP trained dentist Dr Lisa Ravenel adds patient preferred LANAP treatment

Lisa Ravenel DMD discusses the LANAP protocol to treat gum disease

Patients love the fact that LANAP treatment is less invasive with a quicker recovery time than traditional surgery for gum disease. – Dr. Lisa Ravenel, LANAP trained clinician

Greenville Periodontist Dr. Lisa Ravenel now offers the LANAP® protocol to treat patients with gum disease and LAPIP™ protocol for ailing dental implants. As a LANAP-trained clinician, Dr. Ravenel is at the forefront of the future of dentistry, joining a top-tier class of clinicians who put their patients first using FDA-cleared LANAP treatment.

“Gum Disease is a rampant problem and tied to systemic diseases including heart disease and diabetes,” states Dr. Ravenel. “The goal is always to treat the disease, but some patients simply don’t want traditional surgery. Patients love the fact that LANAP treatment is less invasive with a quicker recovery time.”

LANAP treatment targets the bacteria and endotoxins causing gum disease without harming healthy tissue. The recovery time is much quicker and patients report less pain when compared to traditional surgery. The LANAP protocol is also the only treatment of its kind with FDA clearance based on scientific research to regenerate the bone and tissues lost to gum disease.

Studies have shown a link between gum disease and other serious illnesses, such as heart disease, stroke, cancer, diabetes and more. With such a widespread impact on our total health and because it will lead to the gradual destruction of the gums and supporting bone if left untreated, it’s important to address gum disease as early as possible.

If you have gum disease, it may be possible to save many of the teeth that might otherwise be extracted. Research shows that retention of natural teeth has been shown to increase your lifespan!

For information on the LANAP protocol, call Ravenel Periodontics at (864)626-4777 or visit us at RavenelPerio.com

About Dr. Ravenel

Dr. Lisa Ravenel is a Greenville-area native whose love of human physiology and pathology became evident to her in her early 20’s. On a personal note, she takes time to get to know her patients, understand patient goals, and educate them on viable and available options.

She holds degrees from the University of South Carolina and the Medical University of South Carolina for her Bachelor of Science in Biology, Doctorate of Dental Medicine, and specialty training for periodontics and implant surgery, as well as a Masters in Health Sciences. Dr. Ravenel is a member of various organizations, including the American Dental Association, the South Carolina Dental Association, the American Academy of Periodontology, and the Southern Academy of Periodontology.

What she loves most about the specialty is the science-based nature of patient care. Each situation is different and the challenge is to determine what components are needed for success.

Share article on social media or email: